Effects of calcium and magnesium pretreatment on hyperkalaemic cardiac arrest in rats

European Journal of Anaesthesiology

Volumn 20, Issue 8, 2003, Pages 606-611

  Hollmann, M W ^a,b   Strumper D ^c,d   Salmons, V A ^a,e   Washington, J M ^a   Durieux, Marcel E ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e Dermatology Associates of Lancaster   (United States)

Author keywords

Cardiovascular physiology, ventricular function; Homeostasis, electrolyte balance; Vertebrates, rats, Sprague Dawley

Indexed keywords

CALCIUM; CALCIUM CHLORIDE; HALOTHANE; MAGNESIUM; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; HEART ARREST; HEART ARRHYTHMIA; HEART PROTECTION; HYPERKALEMIA; MEAN ARTERIAL PRESSURE; NONHUMAN; POTASSIUM BLOOD LEVEL; RAT; SHOCK; SURVIVAL TIME;

ACID-BASE EQUILIBRIUM; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GAS ANALYSIS; CALCIUM; DISEASE MODELS, ANIMAL; HEART ARREST; HEMODYNAMIC PROCESSES; HEMOGLOBINS; HYPERKALEMIA; MAGNESIUM; MALE; POTASSIUM; PREMEDICATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0041563991     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021503000978     Document Type: Article

References (21)

1. Schulte-Sasse U, Eberlein HJ, Schmucker I, Underwood D, Wolbert R. Should the use of succinylcholine in pediatric anesthesia be re-evaluated? Anaesthesiol Reanim 1993; 18: 13-19.
2. Thapa S, Brull SJ. Succinylcholine-induced hyperkalemia in patients with renal failure: an old question revisited. Anesth Analg 2000; 91: 237-241.
3. MacLennan N, Heimbach DM, Cullen BF. Anesthesia for major thermal injury. Anesthesiology 1998; 89: 749-770.
4. Gronert GA, Theye RA. Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 1975 43: 89-99.
5. Bisogno JL, Langley A, von Dreele MM. Effect of calcium to reverse the electrocardiographic effects of hyperkalemia in the isolated rat heart: a prospective, dose-response study. Crit Care Med 1994; 22: 697-704.
6. Kraft LF, Katholi RE, Woods WT, James TN. Attenuation by magnesium of the electrophysiologic effects of hyperkalemia on human and canine heart cells. Am J Cardiol 1980; 45: 1189-1195.
7. Ifune CK, Steinbach JH. Voltage-dependent block by magnesium of neuronal nicotinic acetylcholine receptor channels in rat phaeochromocytoma cells. J Physiol 1991; 443: 683-701.
8. Levinsky NG. Management of emergencies. VI. Hyperkalemia. N Engl J Med 1966; 274: 1076-1077.
9. Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998; 158: 917-924.
10. Greenberg A. Hyperkalemia: treatment options. Semin Nephrol 1998; 18: 46-57.
11. Nugent M, Tinker JH, Moyer TP. Verapamil worsens rate of development and hemodynamic effects of acute hyperkalemia in halothane-anesthetized dogs: effects of calcium therapy. Anesthesiology 1984; 60: 435-439.
12. Kunis CL, Lowenstein J. The emergency treatment of hypetkalemia. Med Clin North Am 1981; 65: 165-176.
13. Muir KW. New experimental and clinical data on the efficacy of pharmacological magnesium infusions in cerebral infarcts. Magnes Res 1998; 11: 43-56.
14. Gomez MN. Magnesium and cardiovascular disease. Anesthesiology 1998; 89: 222-240.
15. Rochester DF, Arora NS. Respiratory muscle failure. Med Clin North Am 1983; 67: 573-597.
16. Johnson D, Gallagher C, Cavanaugh M, Yip R, Mayers I. The lack of effect of routine magnesium administration on respiratory function in mechanically ventilated patients. Chest 1993; 104: 536-541.
17. Gluckman TJ, Corbridge T. Management of respiratoty failure in patients with asthma. Curr Opin Pulm Med 2000; 6: 79-85.
18. Mangat HS, D'Souza GA, Jacob MS. Nebulized magnesium sulphate vetsus nebulized salbutamol in acute bronchial asthma: a clinical trial. Eur Respir J 1998; 12: 341-344.
19. Mills R, Leadbeater M, Ravalia A. Intravenous magnesium sulphate in the management of refractory bronchospasm in a ventilated asthmatic. Anaesthesia 1997; 52: 782-785.
20. Downey P, Cox R. Update on the management of status asthmaticus. Curr Opin Pediatr 1996; 8: 226-233.
21. Sydow M, Crozier TA, Zielmann S, Radke J, Burchadi H. High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus. Intensive Care Med 1993; 19: 467-471.